| Identification | Back Directory | [Name]
Phosphoramidous acid, bis(1-methylethyl)-, (2R,3R,4S)-2-[2-(acetylamino)-6-[[(diphenylamino)carbonyl]oxy]-9H-purin-9-yl]-4-[bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-furanyl 2-cyanoethyl ester (9CI) | [CAS]
325683-97-4 | [Synonyms]
TNA-O6-DPC-G phosphoramidite
DMTr-T-G(O6-CONPh2)(N2Ac)-amidite
DMTr-TNA-G(O6-CONPh2)(N2Ac)-amidite
DMTr-TNA-G(06-CONPh2)(N2Ac)-amidite
Phosphoramidous acid, bis(1-methylethyl)-, (2R,3R,4S)-2-[2-(acetylamino)-6-[[(diphenylamino)carbonyl]oxy]-9H-purin-9-yl]-4-[bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-furanyl 2-cyanoethyl ester (9CI) | [Molecular Formula]
C54H57N8O9P | [MOL File]
325683-97-4.mol | [Molecular Weight]
993.05 |
| Hazard Information | Back Directory | [Uses]
DMTr-TNA-G(O6-CONPh2)(N2Ac)-amidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
HitGen Inc.
|
| Tel: |
028-85197385 13618381045 |
| Website: |
https://www.hitgen.com/ |
|